As data-driven innovation profoundly changes every industry, the healthcare sector is also affected. Digital twins – virtual copies of physical devices – are essentially changing the ...
After decades of accepting cybersecurity as someone else’s problem, healthcare buyers have reached a turning point. Where cost and functionality once dominated purchasing decisions, cybersecurity ...
Medical device manufacturers use cytotoxicity testing to help prove that devices that come into contact with the human body are biocompatible. Testing results are critical for gaining market access, ...
The Medicines and Healthcare products Regulatory Agency (MHRA) has revealed a record number of device trial approvals in the UK in 2025. During the year, the MHRA approved 17% more clinical ...
TOLEDO, Ohio, Jan. 8, 2026 /PRNewswire/ -- NAMSA, a global leader in medical device testing, clinical research, and regulatory consulting, is pleased to announce it has completed the acquisition of ...
STEMart announces the expansion of its genetic toxicology capabilities with the In Vivo Rat Micronucleus Test services. NEW YORK, NY, UNITED STATES, January 26, 2026 ...
WICHITA, Kan. (KSNW) — Patients who are experiencing a particular form of heart and kidney impairment that isn’t responding to traditional treatment may soon benefit from a new, potentially ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results